BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37878959)

  • 1. Single-Exon Deletions of ZNRF3 Exon 2 Cause Congenital Adrenal Hypoplasia.
    Amano N; Narumi S; Aizu K; Miyazawa M; Okamura K; Ohashi H; Katsumata N; Ishii T; Hasegawa T
    J Clin Endocrinol Metab; 2024 Feb; 109(3):641-648. PubMed ID: 37878959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A ZNRF3-dependent Wnt/β-catenin signaling gradient is required for adrenal homeostasis.
    Basham KJ; Rodriguez S; Turcu AF; Lerario AM; Logan CY; Rysztak MR; Gomez-Sanchez CE; Breault DT; Koo BK; Clevers H; Nusse R; Val P; Hammer GD
    Genes Dev; 2019 Feb; 33(3-4):209-220. PubMed ID: 30692207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures of Wnt-antagonist ZNRF3 and its complex with R-spondin 1 and implications for signaling.
    Peng WC; de Lau W; Madoori PK; Forneris F; Granneman JC; Clevers H; Gros P
    PLoS One; 2013; 8(12):e83110. PubMed ID: 24349440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner.
    Hao HX; Xie Y; Zhang Y; Charlat O; Oster E; Avello M; Lei H; Mickanin C; Liu D; Ruffner H; Mao X; Ma Q; Zamponi R; Bouwmeester T; Finan PM; Kirschner MW; Porter JA; Serluca FC; Cong F
    Nature; 2012 Apr; 485(7397):195-200. PubMed ID: 22575959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZNRF3 acts as a tumour suppressor by the Wnt signalling pathway in human gastric adenocarcinoma.
    Zhou Y; Lan J; Wang W; Shi Q; Lan Y; Cheng Z; Guan H
    J Mol Histol; 2013 Oct; 44(5):555-63. PubMed ID: 23504200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells.
    Qiu W; Yang Z; Fan Y; Zheng Q
    Tumour Biol; 2016 Sep; 37(9):12665-12672. PubMed ID: 27448298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA‑301a/ZNRF3/wnt/β‑catenin signal regulatory crosstalk mediates glioma progression.
    Sun J; Ma Q; Shu C; Xiong J; Li B; Wu J; Zhang S; Li J; Liu J; Wang J
    Int J Oncol; 2021 Jan; 58(1):45-56. PubMed ID: 33367931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activities and mechanisms of the four R-spondins in potentiating Wnt/β-catenin signaling.
    Park S; Cui J; Yu W; Wu L; Carmon KS; Liu QJ
    J Biol Chem; 2018 Jun; 293(25):9759-9769. PubMed ID: 29752411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZnRF3 Induces Apoptosis of Gastric Cancer Cells by Antagonizing Wnt and Hedgehog Signaling.
    Qin H; Cai A; Xi H; Yuan J; Chen L
    Cell Biochem Biophys; 2015 Nov; 73(2):361-367. PubMed ID: 27352324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in Cancer.
    Hao HX; Jiang X; Cong F
    Cancers (Basel); 2016 Jun; 8(6):. PubMed ID: 27338477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZNRF3 functions in mammalian sex determination by inhibiting canonical WNT signaling.
    Harris A; Siggers P; Corrochano S; Warr N; Sagar D; Grimes DT; Suzuki M; Burdine RD; Cong F; Koo BK; Clevers H; Stévant I; Nef S; Wells S; Brauner R; Ben Rhouma B; Belguith N; Eozenou C; Bignon-Topalovic J; Bashamboo A; McElreavey K; Greenfield A
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5474-5479. PubMed ID: 29735715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZNRF3 Inhibits the Invasion and Tumorigenesis in Nasopharyngeal Carcinoma Cells by Inactivating the Wnt/β-Catenin Pathway.
    Wang Z; Wang Y; Ren H; Jin Y; Guo Y
    Oncol Res; 2017 Apr; 25(4):571-577. PubMed ID: 27733215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A MET-PTPRK kinase-phosphatase rheostat controls ZNRF3 and Wnt signaling.
    Kim M; Reinhard C; Niehrs C
    Elife; 2021 Sep; 10():. PubMed ID: 34590584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ub and Dub of RNF43/ZNRF3 in the WNT signalling pathway.
    Colozza G; Koo BK
    EMBO Rep; 2021 May; 22(5):e52970. PubMed ID: 33938624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease associated domain of RNF43 is not necessary for the suppression of Wnt/β-catenin signaling in human cells.
    Radaszkiewicz T; Bryja V
    Cell Commun Signal; 2020 Jun; 18(1):91. PubMed ID: 32527265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCF
    Ci Y; Li X; Chen M; Zhong J; North BJ; Inuzuka H; He X; Li Y; Guo J; Dai X
    Protein Cell; 2018 Oct; 9(10):879-889. PubMed ID: 29497989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RSPO-LGR4/5-ZNRF3/RNF43 module in liver homeostasis, regeneration, and disease.
    Annunziato S; Sun T; Tchorz JS
    Hepatology; 2022 Sep; 76(3):888-899. PubMed ID: 35006616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZNRF3 contributes to the growth of lung carcinoma via inhibiting Wnt/β-catenin pathway and is regulated by miR-93.
    Shi J; Jiang X; Yu Z; He G; Ning H; Wu Z; Cai Y; Yu H; Chen A
    Tumour Biol; 2016 Mar; 37(3):3051-7. PubMed ID: 26423400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlike LGR4, LGR5 potentiates Wnt-β-catenin signaling without sequestering E3 ligases.
    Park S; Wu L; Tu J; Yu W; Toh Y; Carmon KS; Liu QJ
    Sci Signal; 2020 Dec; 13(660):. PubMed ID: 33262293
    [No Abstract]   [Full Text] [Related]  

  • 20. ZNRF3 Regulates Collagen-Induced Arthritis Through NF-kB and Wnt Pathways.
    Liang JJ; Li HR; Chen Y; Zhou Z; Shi YQ; Zhang LL; Xin L; Zhao DB
    Inflammation; 2020 Jun; 43(3):1077-1087. PubMed ID: 32125593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.